 |
|
|
| |
Once-monthly islatravir has no meaningful effect
on exposure to long-acting reversible contraceptives (LARCs)
|
| |
| |
EACS 2023 Oct 18
Michelle Pham*; Prachi Wickremasingha; Ryan Vargo; Munjal Patel; Katherine Nedrow;
Brenda Homony; Michael Robertson; Rebeca M. Plank
Merck & Co., Inc., Rahway, NJ, USA
*Presenting author
An employee of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA, at the time of the study
|
| |
|
|
|
|
|
